Key result
Watchman device offers an LAAO option for stroke prevention in AF patients contraindicated for anticoagulation.
Why the study?
Atrial fibrillation prevalence is projected to double over the next 25 years, demonstrating a need for innovative and effective stroke prevention modalities.
The Watchman device provides a left atrial appendage occlusion option for stroke prevention in patients with atrial fibrillation who have contraindications to anticoagulation.
Atrial fibrillation (AF) is one of the most common sustained dysrhythmias that increases in prevalence with age, and is associated with strokes that can lead to significant patient morbidity and mortality. AF prevalence is projected to double over the next 25 years, demonstrating the need for innovative and effective stroke prevention modalities. Two options are direct oral anticoagulants and left atrial appendage occlusion. This article discusses the Watchman device, a left atrial appendage occlusion device that provides an option for patients with contraindications for anticoagulation.
No takes yet. Share an insight, caveat, or question.
Paamoni et al. (2021) conducted a review in Atrial fibrillation. Watchman device vs. Direct oral anticoagulants was evaluated. The Watchman device provides a left atrial appendage occlusion option for stroke prevention in atrial fibrillation patients with contraindications for anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: